A 65-year-old male is diagnosed as having prostatic cancer based on transrectal biopsy of a 1 cm palpable nodule. Which of the following statement(s) are true concerning his management?
## Core Concept
The management of prostate cancer, especially when detected early through methods like transrectal biopsy of a palpable nodule, involves understanding the stage and grade of the cancer, as well as the patient's overall health. Prostate cancer management options include active surveillance, surgery (prostatectomy), radiation therapy, and hormonal therapy, among others.
## Why the Correct Answer is Right
Given that the details of the options A, B, C, and D are not provided, a general approach to the management of prostate cancer is discussed. For a 65-year-old male with a 1 cm palpable nodule diagnosed as prostate cancer through biopsy, management decisions depend on the cancer's stage, Gleason score, and the patient's life expectancy and preferences.
## Why Each Wrong Option is Incorrect
Since the specific details of options A, B, C, and D are not provided, let's discuss general incorrect statements regarding prostate cancer management:
- **Option A:** Could be incorrect if it suggests a management strategy that is not aligned with current guidelines for early-stage, low-risk prostate cancer, such as immediate radical prostatectomy for low-risk disease.
- **Option B:** Might be incorrect if it recommends a treatment approach that is not suitable for the patient's specific cancer characteristics or overall health status.
- **Option C:** Could be incorrect if it proposes a management plan that does not consider the patient's life expectancy, cancer stage, or patient preferences.
- **Option D:** May be incorrect if it ignores the role of active surveillance, which is often recommended for low-risk prostate cancer.
## Clinical Pearl / High-Yield Fact
A key point to remember is that **active surveillance** is a recommended approach for managing low-risk prostate cancer, especially in older men or those with significant comorbidities, aiming to avoid overtreatment and its side effects. The decision-making process involves considering the **Gleason score**, **PSA levels**, and the patient's **life expectancy** and **preferences**.
## Correct Answer Line
**Correct Answer: D.**